Immune Targeting Systems - Ownership and Business Overview

Life ScienceCompany

Immune Targeting Systems Ownership

Who owns Immune Targeting Systems?

Immune Targeting Systems is owned by Altimmune. It was acquired on February 17, 2015.

Was Immune Targeting Systems formerly PE-backed?

Yes. Immune Targeting Systems was formerly owned by 1 private investor.

Immune Targeting Systems Business Overview

Where is Immune Targeting Systems headquartered?

Immune Targeting Systems is headquartered in London, United Kingdom.

What sector is Immune Targeting Systems in?

Immune Targeting Systems is a life science company.

When was Immune Targeting Systems founded?

Immune Targeting Systems was founded in 2003.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Immune Targeting Systems Ltd.

2 Royal College Street,
London, NW1 0NH
United Kingdom,
+44 20 7691 4908

Immune Targeting Systems Ltd. develops synthetic vaccines for mutating viruses. Immune Targeting Systems enabling the T-cell vaccine platform enables it to target highly conserved parts of the virus (“antigens”) and direct a T-cell immune response to those cells in the body infected with one of these difficult viruses. Immune Targeting Systems was founded in 2003 and is based in London, United Kingdom.


Company Summary

SECTOR

Life Science

Established

2003

 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Immune Targeting Systems

Life Science Companies , United Kingdom Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United Kingdom Companies

Largest United Kingdom Companies , Acquisitive United Kingdom Companies , Recently Acquired United Kingdom Companies , Recently Sold United Kingdom Companies , Private United Kingdom Companies , Public United Kingdom Companies , Acquired United Kingdom Companies , PE Backed United Kingdom Companies
Mergr

Product

Company

Legal